Vonoprazan is Not Inferior to Proton Pump Inhibitors in Bismuth-containing Quadruple Therapy for Helicobacter pylori Eradication: A Meta-analysis of 10 Studies From East Asia.

IF 2.8 4区医学 Q2 GASTROENTEROLOGY & HEPATOLOGY

Journal of clinical gastroenterology Pub Date : 2024-04-12 DOI:10.1097/mcg.0000000000002001

Yujie Cheng, Lin Yang, Si Xu, Chong Zhang

引用次数: 0

Abstract

To investigate the efficacy and safety of vonoprazan based bismuth-containing quadruple therapy (VBCQ) in eradicating Helicobacter pylori (Hp).

查看原文本刊更多论文

在根除幽门螺旋杆菌的含铋四联疗法中，沃诺普拉赞的疗效并不优于质子泵抑制剂：东亚 10 项研究的 Meta 分析。

研究基于冯诺普拉赞的含铋四联疗法（VBCQ）在根除幽门螺杆菌（Hp）方面的有效性和安全性。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Journal of clinical gastroenterology 医学-胃肠肝病学

CiteScore

5.60

自引率

3.40%

发文量

339

审稿时长

3-8 weeks

期刊介绍： Journal of Clinical Gastroenterology gathers the world''s latest, most relevant clinical studies and reviews, case reports, and technical expertise in a single source. Regular features include cutting-edge, peer-reviewed articles and clinical reviews that put the latest research and development into the context of your practice. Also included are biographies, focused organ reviews, practice management, and therapeutic recommendations.